Skip to main content
. 2022 Mar 15;14(3):643. doi: 10.3390/pharmaceutics14030643

Table 2.

Parameters used in simulations with calculated probability that the resulting ratio would fall into the range of 80–125%. CV: intra-subject for cross-over, total for parallel.

Cross-Over Parallel
Simulations 10,000 10,000
Sample size 24 24
CV 73% 96%
Ratios 80–125% 76% 49%